Pages that link to "Q37085343"

The following pages link to Prostate cancer: an emerging threat to the health of aging men in Asia (Q37085343):

Displaying 41 items.

• Dietary antioxidants and prostate cancer: a review (Q26996474) (← links)
• Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer. (Q33885738) (← links)
• Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC-3 human prostate cancer cells (Q34355852) (← links)
• The burden of prostate cancer in Asian nations (Q35890708) (← links)
• Asthma and Risk of Prostate Cancer: A Population-Based Case-Cohort Study in Taiwan (Q36194954) (← links)
• Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis (Q36255272) (← links)
• The Differential Expression and Function of the Inflammatory Chemokine Receptor CXCR5 in Benign Prostatic Hyperplasia and Prostate Cancer (Q36274988) (← links)
• The incidence and mortality of prostate cancer and its relationship with development in Asia (Q36387818) (← links)
• Design and construction of translational medicine platform for urologic oncology (Q36463537) (← links)
• Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls (Q37037551) (← links)
• External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort. (Q37074118) (← links)
• Effects of bortezomib in sensitizing human prostate cancer cell lines to NK-mediated cytotoxicity (Q37074133) (← links)
• The risks, degree of malignancy and clinical progression of prostate cancer associated with the MDM2 T309G polymorphism: a meta-analysis (Q37074138) (← links)
• Analysis of circulating regulatory T cells (CD4+CD25+CD127-) after cryosurgery in prostate cancer (Q37084402) (← links)
• Biomarkers in prostate cancer epidemiology (Q37148139) (← links)
• Epidemiology of prostate cancer in the Asia-Pacific region (Q37270482) (← links)
• Overexpression of transglutaminase 4 and prostate cancer progression: a potential predictor of less favourable outcomes (Q37370501) (← links)
• Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project (Q37700218) (← links)
• The effect of ethnicity and sexual preference on prostate-cancer-related quality of life (Q38001251) (← links)
• Prostate cancer in Asian men. (Q38193300) (← links)
• New concepts concerning prostate cancer screening. (Q38220183) (← links)
• Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases (Q38603373) (← links)
• Clinical significance of CUL4A in human prostate cancer (Q38868184) (← links)
• Anti-proliferative effects of physiological concentrations of enterolactone in models of prostate tumourigenesis. (Q39245540) (← links)
• Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy (Q40181136) (← links)
• MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo. (Q40859822) (← links)
• Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan (Q41861697) (← links)
• The likelihood of having a serum PSA level of ≥2.5 or ≥4.0 ng ml(-1) according to obesity in a screened Korean population (Q42024531) (← links)
• Scientific publications in urology and nephrology journals from China: A 10-year analysis (Q42153552) (← links)
• Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α. (Q45324940) (← links)
• ChIP-seq analysis of androgen receptor in LNCaP cell line. (Q45915898) (← links)
• Enzalutamide in Japanese patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer: A post-hoc analysis of the placebo-controlled PREVAIL trial. (Q46034562) (← links)
• Outcomes of Asian patients with localized prostate cancer treated with combined intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy: A single institution experience (Q47420362) (← links)
• Pin1 promotes prostate cancer cell proliferation and migration through activation of Wnt/β-catenin signaling. (Q53306721) (← links)
• Targeting Splicing in Prostate Cancer. (Q55128284) (← links)
• Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as Influenced by Race, Ethnicity, and Geographic Location (Q57106013) (← links)
• Current and Future Burden of Prostate Cancer in Songkhla, Thailand: Analysis of Incidence and Mortality Trends From 1990 to 2030 (Q57164767) (← links)
• Differences in prostate tumor characteristics and survival among religious groups in Songkhla, Thailand (Q59806525) (← links)
• Human methionine synthase A2756G polymorphism increases susceptibility to prostate cancer (Q90665917) (← links)
• Index-Based Dietary Patterns and the Risk of Prostate Cancer among Iranian Men (Q92286842) (← links)
• The incidence, mortality, and risk factors of prostate cancer in Asian men (Q92772169) (← links)